J. Lutjeboer

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial

R. Zoethout, E. L. van Persijn van Meerten, F. Speetjens, 2022, Trials.

Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial

R. Zoethout, E. L. van Persijn van Meerten, F. Speetjens, 2023, CardioVascular and Interventional Radiology.

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer

L. de Geus-Oei, A. Vahrmeijer, A. V. van Erkel, 2022, PloS one.

Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

L. de Geus-Oei, A. Vahrmeijer, C. Martini, 2020, Annals of Surgical Oncology.

Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

S. Sleijfer, H. Gelderblom, A. Reyners, 2017, Clinical Sarcoma Research.

Assessing the value of volume navigation during ultrasound-guided radiofrequency- and microwave-ablations of liver lesions

N. S. van den Berg, A. V. van Erkel, M. V. van Oosterom, 2021, European journal of radiology open.

Impact on Patient Safety and Satisfaction of Implementation of an Outpatient Clinic in Interventional Radiology (IPSIPOLI-Study): A Quasi-Experimental Prospective Study

A. V. van Erkel, M. Burgmans, Kaman Chung, 2015, CardioVascular and Interventional Radiology.